Cytosorbents CorpNASDAQ:CTSO
- LAST PRICE0.9676
- TODAY'S CHANGE (%)0.1013 (11.6934%)
- Bid / Lots0.9020/ 14
- Ask / Lots0.9600/ 1
- Open / Previous Close0.8657 / 0.8663
- Day Range
- 52 Week Range
- Volume228,725
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CTSO |
|---|---|---|
| 09:36 ET | 250 | 0.8657 |
| 09:52 ET | 100 | 0.8656 |
| 09:59 ET | 100 | 0.86566 |
| 10:14 ET | 100 | 0.8656 |
| 10:21 ET | 100 | 0.86798 |
| 10:30 ET | 250 | 0.88 |
| 10:32 ET | 100 | 0.8656 |
| 10:39 ET | 100 | 0.8656 |
| 10:46 ET | 1600 | 0.87 |
| 10:55 ET | 1100 | 0.8657 |
| 11:02 ET | 200 | 0.8678 |
| 11:08 ET | 100 | 0.87 |
| 11:27 ET | 100 | 0.86785 |
| 11:33 ET | 6300 | 0.8679 |
| 11:36 ET | 758 | 0.8678 |
| 11:40 ET | 100 | 0.8679 |
| 11:51 ET | 2200 | 0.87 |
| 12:02 ET | 400 | 0.87 |
| 12:03 ET | 100 | 0.87 |
| 12:12 ET | 350 | 0.8699 |
| 12:14 ET | 1969 | 0.87 |
| 12:16 ET | 811 | 0.87 |
| 12:20 ET | 10238 | 0.854 |
| 12:25 ET | 400 | 0.85705 |
| 12:27 ET | 100 | 0.86 |
| 12:36 ET | 300 | 0.85755 |
| 12:39 ET | 6895 | 0.86 |
| 12:52 ET | 696 | 0.86 |
| 01:03 ET | 684 | 0.8749 |
| 01:12 ET | 250 | 0.855101 |
| 01:17 ET | 200 | 0.889699 |
| 01:19 ET | 5943 | 0.8945 |
| 01:24 ET | 100 | 0.8744 |
| 01:32 ET | 8600 | 0.8999 |
| 01:39 ET | 4960 | 0.91 |
| 01:53 ET | 100 | 0.89 |
| 01:55 ET | 2686 | 0.91 |
| 01:57 ET | 33965 | 0.9235 |
| 02:00 ET | 100 | 0.9185 |
| 02:02 ET | 100 | 0.9101 |
| 02:04 ET | 100 | 0.91 |
| 02:06 ET | 400 | 0.9124 |
| 02:08 ET | 200 | 0.9124 |
| 02:09 ET | 100 | 0.913 |
| 02:11 ET | 200 | 0.913 |
| 02:13 ET | 350 | 0.920301 |
| 02:15 ET | 100 | 0.93 |
| 02:18 ET | 934 | 0.94 |
| 02:24 ET | 200 | 0.94 |
| 02:26 ET | 200 | 0.9399 |
| 02:27 ET | 200 | 0.94 |
| 02:31 ET | 200 | 0.939 |
| 02:38 ET | 300 | 0.9202 |
| 02:40 ET | 100 | 0.9201 |
| 02:42 ET | 200 | 0.934 |
| 02:47 ET | 300 | 0.9276 |
| 02:51 ET | 100 | 0.934 |
| 02:54 ET | 100 | 0.934 |
| 02:56 ET | 200 | 0.934 |
| 03:02 ET | 200 | 0.934 |
| 03:05 ET | 200 | 0.934 |
| 03:12 ET | 57509 | 0.93505 |
| 03:18 ET | 6449 | 0.9401 |
| 03:21 ET | 1355 | 0.9448 |
| 03:23 ET | 400 | 0.9401 |
| 03:27 ET | 4955 | 0.95 |
| 03:30 ET | 2102 | 0.9401 |
| 03:32 ET | 500 | 0.9401 |
| 03:36 ET | 500 | 0.9401 |
| 03:38 ET | 200 | 0.95 |
| 03:39 ET | 500 | 0.9401 |
| 03:41 ET | 300 | 0.9441 |
| 03:43 ET | 300 | 0.955 |
| 03:45 ET | 238 | 0.955 |
| 03:48 ET | 850 | 0.9575 |
| 03:50 ET | 1141 | 0.955 |
| 03:52 ET | 1993 | 0.955 |
| 03:54 ET | 1841 | 0.965 |
| 03:56 ET | 2172 | 0.965 |
| 03:57 ET | 2624 | 0.9606 |
| 03:59 ET | 850 | 0.9676 |
May 15, 2024
DJ Cytosorbents Price Target Maintained With a $3.00/Share by B. Riley Securities, from 10:16AM ET on Wednesday May 15, 2024 by Dow Jones
10:16AM ET on Wednesday May 15, 2024 by Dow Jones
May 9, 2024
*DJ Cytosorbents 1Q Loss/Shr 12c >CTSO, from 4:17PM ET on Thursday May 09, 2024 by Dow Jones
4:17PM ET on Thursday May 09, 2024 by Dow JonesCytoSorbents Reports First Quarter 2024 Results, from 4:17PM ET on Thursday May 09, 2024 by Dow Jones
4:17PM ET on Thursday May 09, 2024 by Dow Jones
May 7, 2024
DJ Cytosorbents Price Target Maintained With a $1.00/Share by HC Wainwright & Co., from 7:06AM ET on Tuesday May 07, 2024 by Dow Jones
7:06AM ET on Tuesday May 07, 2024 by Dow Jones
May 2, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cytosorbents Corp | 52.5M | -1.6x | --- |
Bionano Genomics Inc | 76.2M | -0.2x | --- |
LENSAR Inc | 47.0M | -3.6x | --- |
STRATA Skin Sciences Inc | 13.8M | -1.2x | --- |
Aamaxan Transport Group Inc | 1.6K | 0.0x | --- |
Dynatronics Corp | 2.2M | -0.4x | --- |
Company Information
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis. Its other products include CytoSorb, animal-targeted VetResQ, DrugSorb-ATR and ECOS-300CY. Its other product candidates under development, including CytoSorb XL, BetaSorb, ContrastSorb, DrugSorb, HemoDefend-RBC, HemoDefend-BGA, K+ontrol, and others consist of a cartridge containing adsorbent, porous polymer beads, although the polymers used in these devices are physically different.
Contact Information
- Headquarters
- 305 COLLEGE ROAD EASTPRINCETON, NJ, United States 08540
- Phone
- 973-329-8885
- Fax
- ---
Executives
- President, Chief Operating Officer
- Vincent Capponi
- Chief Executive Officer, Director
- Phillip Chan
- Chief Financial Officer
- Kathleen Bloch
- Chief Medical Officer
- Efthymios Deliargyris
- Independent Director
- Michael Bator
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $52.5M |
|---|---|
Revenue (TTM) | $36.7M |
Shares Outstanding | 54.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-0.59 |
Book Value | $0.43 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -76.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
